[
    {
        "outcome_uid": "918aa04b",
        "clinical_question": "Should patients with RA on two or more DMARDs who are at target for six months and longer withdraw DMARDs or continue DMARDs?",
        "population": "Patients with RA on two or more DMARDs at target for six months and longer",
        "intervention": "Withdraw one DMARD (or more than one DMARD as long as the patient remains on at least one DMARD)",
        "comparator": "Continue current therapy",
        "outcome": "Disease activity (follow up: 3 months; assessed with: DAS28-ESR (Lower values \u2013 > benefit) (MCID -1.17)",
        "importance": "CRITICAL",
        "related_paper_list": [
            "3ca3e366"
        ],
        "assessment_results": {
            "GRADE": {
                "Risk of bias": {
                    "result": "SERIOUS",
                    "rationales": "Concern about the lack of blinding of participants and providers"
                },
                "Inconsistency": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Indirectness": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Imprecision": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Other considerations": {
                    "result": "none",
                    "rationales": ""
                },
                "Study design": "Randomized Controlled Trial",
                "Certainty": "MODERATE",
                "No of participants": {
                    "Withdraw one DMARD": "64",
                    "Continue current therapy": "73"
                },
                "Annotation": {},
                "Effect": {
                    "Relative Effect (95% CI)": "-",
                    "Absolute Effect (95% CI)": "MD 0.1 higher (0.02 higher to 0.18 higher)",
                    "Abbreviations": "CI: Confidence interval; RR: Risk ratio; MD: Mean difference; HR: Hazard Ratio"
                }
            }
        }
    },
    {
        "outcome_uid": "251b7771",
        "clinical_question": "Should patients with RA on two or more DMARDs who are at target for six months and longer withdraw DMARDs or continue DMARDs?",
        "population": "Patients with RA on two or more DMARDs at target for six months and longer",
        "intervention": "Withdraw one DMARD (or more than one DMARD as long as the patient remains on at least one DMARD)",
        "comparator": "Continue current therapy",
        "outcome": "Flare (follow up: range 11 months to 18 months)",
        "importance": "CRITICAL",
        "related_paper_list": [
            "3ca3e366",
            "60bbc82c",
            "1ce3bb38"
        ],
        "assessment_results": {
            "GRADE": {
                "Risk of bias": {
                    "result": "SERIOUS",
                    "rationales": "All included studies are at risk of bias"
                },
                "Inconsistency": {
                    "result": "SERIOUS",
                    "rationales": "I2=55%"
                },
                "Indirectness": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Imprecision": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Other considerations": {
                    "result": "none",
                    "rationales": ""
                },
                "Study design": "Randomized Controlled Trial",
                "Certainty": "LOW",
                "No of participants": {
                    "Withdraw one DMARD": "645",
                    "Continue current therapy": "382(25.4%)"
                },
                "Annotation": {},
                "Effect": {
                    "Relative Effect (95% CI)": "HR 2.61 (2.11 to 3.23)",
                    "Absolute Effect (95% CI)": "281 more per 1,000 (from 207 more to 358 more)",
                    "Abbreviations": "CI: Confidence interval; RR: Risk ratio; MD: Mean difference; HR: Hazard Ratio"
                }
            }
        }
    },
    {
        "outcome_uid": "832b89f9",
        "clinical_question": "Should patients with RA on two or more DMARDs who are at target for six months and longer withdraw DMARDs or continue DMARDs?",
        "population": "Patients with RA on two or more DMARDs at target for six months and longer",
        "intervention": "Withdraw one DMARD (or more than one DMARD as long as the patient remains on at least one DMARD)",
        "comparator": "Continue current therapy",
        "outcome": "Disability (follow up: 3 months; assessed with: HAQ-DI (Lower values \u2013 > benefit) (MCID -0.22)",
        "importance": "IMPORTANT",
        "related_paper_list": [
            "3ca3e366"
        ],
        "assessment_results": {
            "GRADE": {
                "Risk of bias": {
                    "result": "SERIOUS",
                    "rationales": "Concern about the lack of blinding of participants and providers"
                },
                "Inconsistency": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Indirectness": {
                    "result": "NOT_SERIOUS",
                    "rationales": ""
                },
                "Imprecision": {
                    "result": "SERIOUS",
                    "rationales": "CI includes both values suggesting harms and values suggesting no effect"
                },
                "Other considerations": {
                    "result": "none",
                    "rationales": ""
                },
                "Study design": "Randomized Controlled Trial",
                "Certainty": "LOW",
                "No of participants": {
                    "Withdraw one DMARD": "64",
                    "Continue current therapy": "73"
                },
                "Annotation": {},
                "Effect": {
                    "Relative Effect (95% CI)": "-",
                    "Absolute Effect (95% CI)": "MD 0.09 higher (0.11 lower to 0.29 higher)",
                    "Abbreviations": "CI: Confidence interval; RR: Risk ratio; MD: Mean difference; HR: Hazard Ratio"
                }
            }
        }
    }
]